VBLT logo

Vascular Biogenics (VBLT) Net Income

VBLT Annual Net Income

-$32.30 M
-$2.38 M-7.97%

31 December 2022

1-Year Change

-7.97%
VBLT annual net profit is down -7.97% year-on-year

3-Year Change

-66.55%
VBLT annual net profit is down -66.55% over the past 3 years

All-time High

-$10.14 M

Annual Net Income Formula

Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
Annual Net Margin-4909.42%
VBLT annual net profit margin is -4909.42%
Annual Revenue$658.00 K
VBLT annual revenue is $658.00 thousand
Annual EPS-$0.42
VBLT annual earnings per share is -$0.42

VBLT Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VBLT Quarterly Net Income

-$874.00 K
+$1.76 M+66.88%

30 June 2023

1-Year Change

+90.74%
VBLT quarterly net profit is up +90.74% year-on-year

3-Year Change

+85.01%
VBLT quarterly net profit is up +85.01% over the past 3 years

All-time High

$6.31 M
VBLT quarterly net profit is currently -113.86% below its historical high of $6.31 million
Quarterly Gross Profit$0.00
VBLT quarterly gross profit is $0.00
Quarterly EPS-$0.01
VBLT quarterly earnings per share is -$0.01

VBLT Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VBLT TTM Net Income

-$15.96 M
+$8.56 M+34.92%

30 June 2023

1-Year Change

+55.02%
VBLT TTM net profit is up +55.02% year-on-year

3-Year Change

+26.5%
VBLT TTM net profit is up +26.5% over the past 3 years

All-time High

-$4.57 M
Annual Net Margin-4909.42%
VBLT annual net profit margin is -4909.42%
TTM Gross Profit$464.00 K
VBLT TTM gross profit is $464.00 thousand
TTM EPS-$0.21
VBLT TTM earnings per share is -$0.21

VBLT TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VBLT Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.0%+90.7%+55.0%
3 y3 years-66.5%+85.0%+26.5%
5 y5 years-218.6%+78.4%+17.7%

VBLT Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time+218.6%-113.9%+249.0%

Vascular Biogenics Net Income History

DateAnnualQuarterlyTTM
June 2023
-
-$874.00 K(-66.9%)
-$15.96 M(-34.9%)
Mar 2023
-
-$2.64 M(-19.3%)
-$24.52 M(-24.1%)
Dec 2022
-$32.30 M(+8.0%)
-$3.27 M(-64.3%)
-$32.30 M(-15.3%)
Sept 2022
-
-$9.17 M(-2.8%)
-$38.14 M(+7.5%)
June 2022
-
-$9.43 M(-9.5%)
-$35.47 M(+4.1%)
Mar 2022
-
-$10.43 M(+14.5%)
-$34.06 M(+13.9%)
Dec 2021
-$29.92 M(+23.5%)
-$9.11 M(+40.1%)
-$29.92 M(+6.6%)
Sept 2021
-
-$6.50 M(-19.0%)
-$28.08 M(+2.6%)
June 2021
-
-$8.03 M(+27.8%)
-$27.35 M(+8.7%)
Mar 2021
-
-$6.28 M(-13.5%)
-$25.16 M(+3.8%)
Dec 2020
-$24.23 M(+24.9%)
-$7.26 M(+25.7%)
-$24.23 M(+7.0%)
Sept 2020
-
-$5.78 M(-0.9%)
-$22.63 M(+4.3%)
June 2020
-
-$5.83 M(+8.9%)
-$21.71 M(+5.5%)
Mar 2020
-
-$5.35 M(-5.6%)
-$20.57 M(+6.0%)
Dec 2019
-$19.40 M(-5.4%)
-$5.67 M(+16.7%)
-$19.40 M(+10.0%)
Sept 2019
-
-$4.86 M(+3.5%)
-$17.64 M(-2.7%)
June 2019
-
-$4.69 M(+12.1%)
-$18.14 M(+3.6%)
Mar 2019
-
-$4.18 M(+6.9%)
-$17.50 M(-14.6%)
Dec 2018
-$20.50 M
-$3.91 M(-26.9%)
-$20.50 M(+99.4%)
Sept 2018
-
-$5.35 M(+32.0%)
-$10.28 M(-10.4%)
DateAnnualQuarterlyTTM
June 2018
-
-$4.05 M(-43.5%)
-$11.46 M(-6.7%)
Mar 2018
-
-$7.18 M(-213.8%)
-$12.28 M(+21.2%)
Dec 2017
-$10.14 M(-36.6%)
$6.31 M(-196.5%)
-$10.14 M(-52.3%)
Sept 2017
-
-$6.54 M(+34.2%)
-$21.25 M(+18.7%)
June 2017
-
-$4.87 M(-3.2%)
-$17.91 M(+9.8%)
Mar 2017
-
-$5.03 M(+4.8%)
-$16.31 M(+1.9%)
Dec 2016
-$16.00 M(+7.5%)
-$4.80 M(+50.4%)
-$16.00 M(+11.5%)
Sept 2016
-
-$3.19 M(-2.4%)
-$14.36 M(-15.3%)
June 2016
-
-$3.27 M(-30.8%)
-$16.95 M(+1.9%)
Mar 2016
-
-$4.73 M(+49.7%)
-$16.64 M(+11.8%)
Dec 2015
-$14.89 M(-14.5%)
-$3.16 M(-45.4%)
-$14.89 M(-11.7%)
Sept 2015
-
-$5.79 M(+95.2%)
-$16.86 M(+15.6%)
June 2015
-
-$2.96 M(-0.4%)
-$14.59 M(-4.8%)
Mar 2015
-
-$2.98 M(-42.0%)
-$15.33 M(-11.9%)
Dec 2014
-$17.41 M(+0.2%)
-$5.13 M(+46.1%)
-$17.41 M(-1.5%)
Sept 2014
-
-$3.52 M(-5.0%)
-$17.68 M(-5.6%)
June 2014
-
-$3.70 M(-26.8%)
-$18.73 M(+24.6%)
Mar 2014
-
-$5.05 M(-6.5%)
-$15.03 M(+50.7%)
Dec 2013
-$17.37 M(+42.1%)
-$5.41 M(+18.3%)
-$9.98 M(+118.3%)
Sept 2013
-
-$4.57 M
-$4.57 M
Dec 2012
-$12.22 M
-
-

FAQ

  • What is Vascular Biogenics annual net profit?
  • What is the all time high annual net income for Vascular Biogenics?
  • What is Vascular Biogenics annual net income year-on-year change?
  • What is Vascular Biogenics quarterly net profit?
  • What is the all time high quarterly net income for Vascular Biogenics?
  • What is Vascular Biogenics quarterly net income year-on-year change?
  • What is Vascular Biogenics TTM net profit?
  • What is the all time high TTM net income for Vascular Biogenics?
  • What is Vascular Biogenics TTM net income year-on-year change?

What is Vascular Biogenics annual net profit?

The current annual net income of VBLT is -$32.30 M

What is the all time high annual net income for Vascular Biogenics?

Vascular Biogenics all-time high annual net profit is -$10.14 M

What is Vascular Biogenics annual net income year-on-year change?

Over the past year, VBLT annual net profit has changed by -$2.38 M (-7.97%)

What is Vascular Biogenics quarterly net profit?

The current quarterly net income of VBLT is -$874.00 K

What is the all time high quarterly net income for Vascular Biogenics?

Vascular Biogenics all-time high quarterly net profit is $6.31 M

What is Vascular Biogenics quarterly net income year-on-year change?

Over the past year, VBLT quarterly net profit has changed by +$8.56 M (+90.74%)

What is Vascular Biogenics TTM net profit?

The current TTM net income of VBLT is -$15.96 M

What is the all time high TTM net income for Vascular Biogenics?

Vascular Biogenics all-time high TTM net profit is -$4.57 M

What is Vascular Biogenics TTM net income year-on-year change?

Over the past year, VBLT TTM net profit has changed by +$19.52 M (+55.02%)